Clinical trials
Aged 65 Years or Older clinical trials
Below are recruiting aged 65 years or older clinical trials, each written for real people, not researchers. We’re tracking 1,068 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07497529Recruiting
WhatsApp Exercise Program for Adults 60+
This study tests a gentle exercise program (Radio Taiso) delivered through WhatsApp to help adults 60+ stay active at home. If you have a smartphone and can walk, this low-impact program may be a good fit for you.
SamsunAges 60 years+ - NCT07476859RecruitingPhase 4
Iron for heart attack recovery in older adults
This study tests whether giving iron through a vein can improve quality of life in older adults who recently had a heart attack or unstable angina and also have low iron levels. If you qualify, you would receive either iron or a placebo (inactive substance) to see if iron helps you feel better and recover faster.
El Palmar, MurciaAges 65 years+ - NCT07448818Recruiting
Strength training for older adults with high blood pressure
This study tests whether different types of strength training (dynamic and isometric) can help older adults with high blood pressure who are already taking medication. It's designed for people who are not very active and have no major health risks.
São Paulo, São PauloAges 60 years+ - NCT07438054Enrolling by invitation
Yearly heart-rhythm screening for adults 65 and older
This study tests whether monthly heart checks using a simple ECG (a quick test of your heart's electrical activity) can find a common heart-rhythm problem called atrial fibrillation earlier. You would visit your family health center once a month for 12 months to get the ECG done, no extra procedures or treatments are involved.
Ordu, OrduAges 65 years+ - NCT07412379Recruiting
Predicting recovery after cancer surgery for older adults
This study looks at how older adults (65+) with digestive tract cancers respond to surgery aimed at a cure. Researchers want to see what factors affect recovery and quality of life after the operation.
BogotáAges 65 years+ - NCT07394790Recruiting
Exercise program for adults 65 and older
This study tests if a personalized exercise program prescribed by your doctor can help people 65 and older stay active and healthy. You would meet with a healthcare team to get a simple exercise plan and see how it affects your well-being.
Villoría, SalamancaAges 65 years+ - NCT07297602RecruitingPhase 2
Oral roflumilast for moderate to severe eczema in teens and adults
This study tests an oral medicine called roflumilast to see if it helps treat moderate to severe eczema in people aged 12 and up who haven't used other systemic treatments recently. It's a pilot study to check both safety and how well it works.
Al Mansurah, Dakahlia GovernorateAges 12 years+ - NCT07265674RecruitingPhase 3
Study of nanvuranlat for advanced bile duct cancer
This study tests a new drug called nanvuranlat for people with advanced bile duct cancer that has gotten worse after platinum-based chemotherapy. It compares nanvuranlat with the doctor's choice of standard treatments to see which works better.
Duarte, CaliforniaAges 18 years+ - NCT06874842RecruitingPhase 1
Testing a new shingles vaccine in adults 40 and older
This trial tests a new shingles vaccine (LYB004) in adults 40 and older. It looks at how safe the vaccine is and how well it helps your body build protection against shingles.
MeizhouAges 40 years+ - NCT07241299Recruiting
Understanding long-term medications in adults 65+
This study looks at how people aged 65 and older understand their long-term medications (treatments taken for more than 3 months). It aims to improve communication between patients and doctors.
Reims, Université de Reims Champagne-ArdenneAges 65 years+ - NCT07196644RecruitingPhase 2
A study of a new drug for certain cancers with a specific gene change
This trial tests a drug called telisotuzumab adizutecan for people whose cancer has a specific genetic change called MET amplification. It may help when standard treatments are no longer working.
Beverly Hills, CaliforniaAges 12 years+ - NCT07086976RecruitingPhase 3
Study of oral rilzabrutinib for warm autoimmune hemolytic anemia
This trial tests an oral medication (rilzabrutinib) against a placebo for people with warm autoimmune hemolytic anemia (wAIHA). It aims to see if the drug can help control the disease with fewer side effects than current treatments.
Phoenix, ArizonaAges 18 years+ - NCT07088926RecruitingPhase 2
Study of a new drug for bronchiectasis with chronic pseudomonas infection
This study tests an investigational drug given through an IV to see if it can reduce lung infections and flare-ups in people with bronchiectasis who have a chronic pseudomonas infection. Participation may help improve symptoms and quality of life.
Orange, CaliforniaAges 12 years+ - NCT06972537Recruiting
Piperacillin-Tazobactam Dosing for Pneumonia in Older Adults
This study looks at the best way to give the antibiotic piperacillin-tazobactam (Zosyn) to people 65 and older who have pneumonia. It aims to make treatment more effective and safer for older adults.
Jinan, ShandongAges 65–100 - NCT06962696Recruiting
Testing AI to check home safety for older adults
This trial uses a smart computer program (GPT-4o) to check the safety of your home environment and see if it's safe for older adults. It's designed for seniors who live at home and can communicate easily.
Beijing, Beijing MunicipalityAges 65 years+ - NCT06915233RecruitingPhase 3
MACI for ankle cartilage defects in adults
This trial tests a treatment called MACI for people with damaged cartilage in their ankle. It uses your own cells to grow new cartilage, which may help reduce pain and improve how you can use your ankle.
Sacramento, CaliforniaAges 17–65 - NCT06891885RecruitingPhase 1/Phase 2
Safety study of DSP-3077 for retinitis pigmentosa
This trial tests a new medicine, DSP-3077, given as a single injection into one eye to see if it is safe for people with retinitis pigmentosa. It is for adults with advanced vision loss who have no other major eye diseases.
Boston, MassachusettsAges 18 years+ - NCT06873945RecruitingPhase 3
Study of two doses of ritlecitinib for alopecia areata
This study tests two different doses of a pill called ritlecitinib to see if it can help regrow hair in people with significant hair loss from alopecia areata. It is for people aged 12 and older who have lost at least half of their scalp hair.
Birmingham, AlabamaAges 12 years+ - NCT06831942Recruiting
Suicide prevention counseling for adults 65 and older
This study tests a short counseling program for older adults (65+) who have recently attempted suicide or had serious suicidal thoughts. The program is designed to help reduce the risk of future suicide attempts. It is offered alongside your regular mental health care.
BoråsAges 65 years+ - NCT06807281RecruitingPhase 3
Abrocitinib for children with eczema: long-term study
This study tests the long-term safety and effectiveness of abrocitinib (Cibinqo) for children aged 6 to 12 with moderate to severe eczema that hasn't improved with creams. It may help their skin clear and reduce itching.
Birmingham, AlabamaAges 2–11 - NCT06666491RecruitingPhase 3
Comparing two malaria treatments for P. vivax in people 2 and older
This study compares two medicines (tafenoquine and primaquine) taken with chloroquine to treat P. vivax malaria. It aims to see which is safer and works better in Indian participants aged 2 to 64.
AhmedabadAges 2–64 - NCT06431893Enrolling by invitationPhase 3
Long-term study of pegtibatinase for classical homocystinuria
This trial is a long-term follow-up study examining the safety and effectiveness of pegtibatinase for people with classical homocystinuria (HCU). It is open to those who have recently taken part in or finished the HARMONY or COMPOSE studies.
Phoenix, ArizonaAges 5–65 - NCT06416618Recruiting
Surgery vs. No Surgery for Shoulder Fracture, Ages 50-65
This trial compares surgery versus non-surgical treatment for a broken shoulder bone (proximal humerus) in adults aged 50 to 65. It aims to find which approach leads to better recovery and function.
Køge, Region SjællandAges 50–65 - NCT05928767Recruiting
Using frailty scores to predict death in ICU sepsis
This trial checks whether a “frailty” rating (how physically/mentally vulnerable someone is) can predict the risk of death in ICU patients with sepsis shock. It may help doctors identify higher-risk patients earlier and tailor care.
BéthuneAges 18–65
Hear when a new Aged 65 Years or Older trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for aged 65 years or older?
- Yes. Clin2 currently lists 1,068 recruiting aged 65 years or older studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a aged 65 years or older trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a aged 65 years or older trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.